Sign in

NCT06259019Recruiting

Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease

Site of Disease BIOmolecule Capture and Analysis in PATienTs With Established Coronary Disease undERgoing iNtracoronary Assessment

Source: ClinicalTrials.gov · Last updated 3 Apr 2026

Brief summary (registry, in English)

The aim of this research, proposed and funded by PlaqueTec and co-ordinated by Papworth Trials Unit Collaboration, is to demonstrate the performance of the coronary artery blood sampling device (Liquid Biospy System, LBS) and establish its usefulness to collect a range of disease biomolecules from the coronary artery of interest. Using the data generated from extensive analysis of the blood samples, key biomarker data will be generated that will close a knowledge gap and facilitate the development of tailored treatments for coronary artery disease.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
300 (estimated)
First submitted
12 Dec 2023
Start date
14 Sept 2023
Primary completion date
31 Dec 2027
Lead sponsor
PlaqueTec Ltd
NCT number
NCT06259019

What you commit to

  • Study type: Interventional
  • Planned participants: 300
  • From 14 Sept 2023 to the primary completion date, 31 Dec 2027
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Immunocompromised or receiving immunosuppressant therapy.
  • Prior PCI or stent or graft in vessel identified for LBS sampling.

Other illness

  • Myocardial Infarction within 30 days of procedure.
  • Contrast allergy.
  • Ventricular arrhythmia.
  • Any active disease that in the opinion of the investigator makes the subject unsuitable for the research procedure or subject life expectancy less than 1 year.
  • Active infection or sepsis (significant CRP elevation and/or requiring antibiotics).
  • Active systemic inflammatory condition.
  • Unsuitable coronary anatomy (vessel tortuosity \[\>45 degree bend\], moderate/ severe calcification angiographically, ostial disease).

Lab values

  • Chronic renal failure (eGFR\<30ml/min/1.73m2).
  • Chronic Heart Failure (NYHA ≥ 3) or LVEF ≤ 30%.
  • Inability to receive anticoagulants or antiplatelets or uncorrected bleeding disorder or deranged platelet count.

Other

  • Stage 1 screening exclusion:
  • Hypotension, shock or haemodynamic instability.
  • Is pregnant.
  • Deemed high clinical risk or unsuitable for the procedure for any reason by the treating clinician.
    • Stage 2 screening exclusion:
  • Target lesion is in the left main coronary artery.
  • Presence of thrombus in the target vessel.
  • No clinical indication for either a PCI or a pressure wire assessment on any lesion.

Who the study is looking for

  • Stage 1 screening inclusion:
  • ≥18 years of age, have capacity and be willing to provide informed consent to participate
  • Clinical evidence of obstructive coronary artery disease and be scheduled for either:
    • Elective coronary angiography +/- proceed for stable angina OR
    • Elective PCI for stable angina with known bystander disease OR
    • Angiography +/- proceed for Troponin negative unstable angina
    • Stage 2 screening inclusion:
    • Suitable lesion identified meeting angiographic criteria for LBS deployment and Cardiologist comfortable to deploy OCT and LBS on study lesion before carrying out PCI on any lesion

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Royal Bournemouth Hospital
Coordinator of this site? Confirm its status
BournemouthUnited KingdomRecruiting
Bristol Heart Institute
Coordinator of this site? Confirm its status
BristolUnited KingdomRecruiting
Royal Papworth Hospital
Coordinator of this site? Confirm its status
CambridgeUnited KingdomRecruiting
Norfolk And Norwich Hospital
Coordinator of this site? Confirm its status
NorwichUnited KingdomRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.